Cargando…

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection

This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal sched...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guaraldi, Giovanni, Rossotti, Roberto, Verucchi, Gabriella, Tavio, Marcello, Pasulo, Luisa, Beghetto, Barbara, Dolci, Giovanni, Nardini, Giulia, Badia, Lorenzo, Magliano, Anna, Moioli, Maria Cristina, Puoti, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451199/ https://www.ncbi.nlm.nih.gov/pubmed/28584851 http://dx.doi.org/10.1093/ofid/ofx065

Ejemplares similares

Molecular Imaging of Vascular Calcification with (18)F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus
por: Raggi, Paolo, et al.
Publicado: (2019)

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
por: Merli, Marco, et al.
Publicado: (2021)

Top topics in HCV research arena
por: Puoti, Massimo, et al.
Publicado: (2012)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
por: He, Xiaoping, et al.
Publicado: (2017)

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
por: Guardigni, Viola, et al.
Publicado: (2017)

Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles
por: Guaraldi, Giovanni, et al.
Publicado: (2015)

Efficacy and safety of Sofosbuvir-containing regimens in patients co-infected with chronic hepatitis C virus and human immunodeficiency virus: a meta-analysis
por: Li, Guotao, et al.
Publicado: (2018)

Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-Infection
por: Havens, Joshua P., et al.
Publicado: (2020)

Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus Infection
por: Leung, Janice M, et al.
Publicado: (2016)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
por: Dharnidharka, Vikas R., et al.
Publicado: (2019)

Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus
por: Yunihastuti, Evy, et al.
Publicado: (2021)

Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort
por: Quaranta, Maria Giovanna, et al.
Publicado: (2020)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection
por: Khemnark, Suparat, et al.
Publicado: (2023)

Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
por: de Freitas, Caroline S., et al.
Publicado: (2019)

Posttransplant infections
por: Thomas, Beje, et al.
Publicado: (2019)

Epstein-Barr virus associated posttransplant malignant lymphoma in renal allograft recipients.
por: Choi, Y. J., et al.
Publicado: (1994)

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)

Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
por: Thalhammer, Julian, et al.
Publicado: (2021)

Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study
por: Franceschini, Erica, et al.
Publicado: (2017)

The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
por: Barillari, Giovanni
Publicado: (2020)

SUN-456 Serum Sodium Is Inversely Related to Frailty and Bone Mineral Density (BMD) in Human Immunodeficiency Virus (HIV)-Infected Patients
por: De Vincentis, Sara, et al.
Publicado: (2019)

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017)

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease
por: Kinoshita, Hannah, et al.
Publicado: (2022)

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control
por: Joharji, Hala, et al.
Publicado: (2022)

Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?
por: Mangia, Alessandra, et al.
Publicado: (2020)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Posttransplant Metabolic Syndrome
por: Siddiqui, M. Shadab, et al.
Publicado: (2012)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Posttransplant Intrarenal Lymphangiectasia
por: Kord, Ali, et al.
Publicado: (2020)

Posttransplant Complications and Comorbidities
por: Danziger-Isakov, Lara, et al.
Publicado: (2018)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

SAT-050 Low Serum Testosterone (T) Is Associated with Poor Health Status in Young to Middle-Aged Human Immunodeficiency Virus (HIV)-Infected Men
por: Vincentis, Sara De, et al.
Publicado: (2020)

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
por: Sundaram, Vinay, et al.
Publicado: (2016)

Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population
por: Stewart, Rachel A., et al.
Publicado: (2018)

Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017)

Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection
por: Ahmed, Rowan, et al.
Publicado: (2021)

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
por: Huisman, W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fna7av84kv1brsvjha7kkc5hjg